82 related articles for article (PubMed ID: 15158095)
21. BCL6 modulation of acute lymphoblastic leukemia response to chemotherapy.
Slone WL; Moses BS; Hare I; Evans R; Piktel D; Gibson LF
Oncotarget; 2016 Apr; 7(17):23439-53. PubMed ID: 27015556
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of BAD phosphorylation either at serine 112 via extracellular signal-regulated protein kinase cascade or at serine 136 via Akt cascade sensitizes human ovarian cancer cells to cisplatin.
Hayakawa J; Ohmichi M; Kurachi H; Kanda Y; Hisamoto K; Nishio Y; Adachi K; Tasaka K; Kanzaki T; Murata Y
Cancer Res; 2000 Nov; 60(21):5988-94. PubMed ID: 11085518
[TBL] [Abstract][Full Text] [Related]
23. Phosphatidylinositol 3-kinase coordinately activates the MEK/ERK and AKT/NFkappaB pathways to maintain osteoclast survival.
Gingery A; Bradley E; Shaw A; Oursler MJ
J Cell Biochem; 2003 May; 89(1):165-79. PubMed ID: 12682917
[TBL] [Abstract][Full Text] [Related]
24. Bcl-2 phosphorylation and apoptosis activated by damaged microtubules require mTOR and are regulated by Akt.
Asnaghi L; Calastretti A; Bevilacqua A; D'Agnano I; Gatti G; Canti G; Delia D; Capaccioli S; Nicolin A
Oncogene; 2004 Jul; 23(34):5781-91. PubMed ID: 15208671
[TBL] [Abstract][Full Text] [Related]
25. Involvement of Bcl-2 family members, phosphatidylinositol 3'-kinase/AKT and mitochondrial p53 in curcumin (diferulolylmethane)-induced apoptosis in prostate cancer.
Shankar S; Srivastava RK
Int J Oncol; 2007 Apr; 30(4):905-18. PubMed ID: 17332930
[TBL] [Abstract][Full Text] [Related]
26. Rosiglitazone and PPAR-gamma overexpression protect mitochondrial membrane potential and prevent apoptosis by upregulating anti-apoptotic Bcl-2 family proteins.
Wu JS; Lin TN; Wu KK
J Cell Physiol; 2009 Jul; 220(1):58-71. PubMed ID: 19229877
[TBL] [Abstract][Full Text] [Related]
27. Adhesion-induced drug resistance in leukemia stem cells.
Funayama K; Murai F; Shimane M; Nomura H; Asano S
Pharmacology; 2010; 86(2):79-84. PubMed ID: 20689339
[TBL] [Abstract][Full Text] [Related]
28. PKC alpha mediates chemoresistance in acute lymphoblastic leukemia through effects on Bcl2 phosphorylation.
Jiffar T; Kurinna S; Suck G; Carlson-Bremer D; Ricciardi MR; Konopleva M; Andreeff M; Ruvolo PP
Leukemia; 2004 Mar; 18(3):505-12. PubMed ID: 14737078
[TBL] [Abstract][Full Text] [Related]
29. Chemotherapy disrupts activity of translational regulatory proteins in bone marrow stromal cells.
Clutter SD; Fortney JE; Gibson LF
Exp Hematol; 2006 Nov; 34(11):1522-31. PubMed ID: 17046572
[TBL] [Abstract][Full Text] [Related]
30. Bcl-x(L) and Akt cooperate to promote leukemogenesis in vivo.
Karnauskas R; Niu Q; Talapatra S; Plas DR; Greene ME; Crispino JD; Rudin CM
Oncogene; 2003 Feb; 22(5):688-98. PubMed ID: 12569361
[TBL] [Abstract][Full Text] [Related]
31. Involvement of extracellular signal-regulated kinases 1/2 and (phosphoinositide 3-kinase)/Akt signal pathways in acquired resistance against neurotoxin of 6-hydroxydopamine in SH-SY5Y cells following cell-cell interaction with astrocytes.
Jiang Z; Yu PH
Neuroscience; 2005; 133(2):405-11. PubMed ID: 15878643
[TBL] [Abstract][Full Text] [Related]
32. Celecoxib-induced apoptosis in rat cholangiocarcinoma cells mediated by Akt inactivation and Bax translocation.
Zhang Z; Lai GH; Sirica AE
Hepatology; 2004 Apr; 39(4):1028-37. PubMed ID: 15057907
[TBL] [Abstract][Full Text] [Related]
33. Prolonged survival of B-lineage acute lymphoblastic leukemia cells is accompanied by overexpression of bcl-2 protein.
Campana D; Coustan-Smith E; Manabe A; Buschle M; Raimondi SC; Behm FG; Ashmun R; Aricò M; Biondi A; Pui CH
Blood; 1993 Feb; 81(4):1025-31. PubMed ID: 8427984
[TBL] [Abstract][Full Text] [Related]
34. Preclinical evaluation of antisense bcl-2 as a chemosensitizer for patients with gastric carcinoma.
Kim R; Emi M; Tanabe K; Toge T
Cancer; 2004 Nov; 101(10):2177-86. PubMed ID: 15476281
[TBL] [Abstract][Full Text] [Related]
35. Epstein-Barr virus (EBV) LMP2A mediates B-lymphocyte survival through constitutive activation of the Ras/PI3K/Akt pathway.
Portis T; Longnecker R
Oncogene; 2004 Nov; 23(53):8619-28. PubMed ID: 15361852
[TBL] [Abstract][Full Text] [Related]
36. Apoptotic induction in B-cell acute lymphoblastic leukemia cell lines treated with a protein kinase Cβ inhibitor.
Saba NS; Levy LS
Leuk Lymphoma; 2011 May; 52(5):877-86. PubMed ID: 21271861
[TBL] [Abstract][Full Text] [Related]
37. Survival of B lineage leukemic cells: signals from the bone marrow microenvironment.
Gibson LF
Leuk Lymphoma; 2002 Jan; 43(1):19-27. PubMed ID: 11908727
[TBL] [Abstract][Full Text] [Related]
38. Activated EGFR promotes the survival of B-lineage acute leukemia in the absence of stromal cells.
Spengeman JD; Green TD; McCubrey JA; Bertrand FE
Cell Cycle; 2005 Mar; 4(3):483-7. PubMed ID: 15701973
[TBL] [Abstract][Full Text] [Related]
39. Clonal variation in the B-lineage acute lymphoblastic leukemia response to multiple cytokines and bone marrow stromal cells.
Shah N; Oseth L; Tran H; Hirsch B; LeBien TW
Cancer Res; 2001 Jul; 61(13):5268-74. PubMed ID: 11431369
[TBL] [Abstract][Full Text] [Related]
40. Bcl-2 protein and apoptosis in pediatric acute lymphoblastic leukemia.
Srinivas G; Kusumakumary P; Nair MK; Panicker KR; Pillai MR
Int J Mol Med; 1998 Apr; 1(4):755-9. PubMed ID: 9852293
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
